K. Van de Vijver - Academia.edu (original) (raw)
Uploads
Papers by K. Van de Vijver
The respiratory abdominal variation test (RAVT): a noninvasive way to estimate abdominal wall compliance (Cab)
Fluids, 2012
Effect of enteral nutrition speed on intrafastric pressure measurement
American Surgeon, 2011
Impact of body anthropomorphic parameters on baseline intra-abdominal pressure measurements in critically ill patients
Fluids, 2012
Body antropomorphic data in relation to intra-abdominal pressure
American Surgeon, 2011
Fluids, 2012
Introduction. Nexfin (Bmeye, Amsterdam, Netherlands) is a noninvasive cardiac output (CO) monitor... more Introduction. Nexfin (Bmeye, Amsterdam, Netherlands) is a noninvasive cardiac output (CO) monitor based on finger arterial pulse contour analysis. The aim of this study was to validate Nexfin CO (NexCO) against thermodilution (TDCO) and pulse contour CO (CCO) by PiCCO (Pulsion Medical Systems, Munich, Germany). Patients and Methods. In a mix of critically ill patients (= 45), NexCO and CCO were measured continuously and recorded at 2-hour intervals during the 8-hour study period. TDCO was measured at 0-4-8 hrs. Results. NexCO showed a moderate to good (significant) correlation with TDCO (2 0.68, < 0.001) and CCO (2 0.71, < 0.001). Bland and Altman analysis comparing NexCO with TDCO revealed a bias (± limits of agreement, LA) of 0.4 ± 2.32 L/min (with 36% error) while analysis comparing NexCO with CCO showed a bias (±LA) of 0.2 ± 2.32 L/min (37% error). NexCO is able to follow changes in TDCO and CCO during the same time interval (level of concordance 89.3% and 81%). Finally, polar plot analysis showed that trending capabilities were acceptable when changes in NexCO (ΔNexCO) were compared to ΔTDCO and ΔCCO (resp., 89% and 88.9% of changes were within the level of 10% limits of agreement). Conclusion. we found a moderate to good correlation between CO measurements obtained with Nexfin and PiCCO.
Minerva anestesiologica, 2014
BACKGROUND Nexfin® (BMEYE, Amsterdam, The Netherlands) is a totally non-invasive blood pressure a... more BACKGROUND Nexfin® (BMEYE, Amsterdam, The Netherlands) is a totally non-invasive blood pressure and cardiac output (CO) monitor based on finger arterial pulse contour analysis. METHODS We performed an open observational study in a mix of medical-surgical-burns critically ill patients (N.=45) to validate Nexfin obtained blood pressures (MAPnex) against PiCCO (MAPfem) derived blood pressure measurements. MAPnex, MAPfem and corresponding systolic (SBP) and diastolic (DBP) blood pressures were measured continuously and registered with a 2 hour interval during the 8-hour study period. Statistical analysis was performed by Pearson regression, Bland and Altman, Concordance plot and Polar plot analysis. RESULTS MAPnex shows excellent correlation with MAPfem (R² 0.88, mean bias ± LA -2.3±12.4 mmHg, 14.7% error) and may be used interchangeably with invasive monitoring. The excellent MAPnex -MAPfem correlation was preserved in subgroup analysis for patients with severe hypotension, high system...
Validation study of Nexfin® continuous non-invasive blood pressure monitoring in critically ill adult patients
Minerva anestesiologica
Nexfin® (BMEYE, Amsterdam, The Netherlands) is a totally noninvasive blood pressure and cardiac o... more Nexfin® (BMEYE, Amsterdam, The Netherlands) is a totally noninvasive blood pressure and cardiac output (CO) monitor based on finger arterial pulse contour analysis. We performed an open observational study in a mix of medical-surgical-burns critically ill patients (n=45) to validate Nexfin obtained blood pressures (MAPnex) against PiCCO (MAPfem). derived blood pressure measurements. MAPnex, MAPfem and corresponding systolic (SBP) and diastolic (DBP) blood pressures were measured continuously and registered with a 2 hour interval during the 8-hour study period. Statistical analysis was performed by Pearson regression, Bland and Altman, Concordance plot and Polar plot analysis. MAPnex shows excellent correlation with MAPfem (R² 0.88, mean bias ± LA 2.3 ± 12.4 mmHg, 14.7% error) and may be used interchangeably with invasive monitoring. The excellent MAPnex MAPfem correlation was preserved in subgroup analysis for patients with severe hypotension, high systemic vascular resistance, low ...
Minerva anestesiologica, 2014
Nexfin® (BMEYE, Amsterdam, The Netherlands) is a totally non-invasive blood pressure and cardiac ... more Nexfin® (BMEYE, Amsterdam, The Netherlands) is a totally non-invasive blood pressure and cardiac output (CO) monitor based on finger arterial pulse contour analysis. We performed an open observational study in a mix of medical-surgical-burns critically ill patients (N.=45) to validate Nexfin obtained blood pressures (MAPnex) against PiCCO (MAPfem) derived blood pressure measurements. MAPnex, MAPfem and corresponding systolic (SBP) and diastolic (DBP) blood pressures were measured continuously and registered with a 2 hour interval during the 8-hour study period. Statistical analysis was performed by Pearson regression, Bland and Altman, Concordance plot and Polar plot analysis. MAPnex shows excellent correlation with MAPfem (R² 0.88, mean bias ± LA -2.3±12.4 mmHg, 14.7% error) and may be used interchangeably with invasive monitoring. The excellent MAPnex -MAPfem correlation was preserved in subgroup analysis for patients with severe hypotension, high systemic vascular resistance, low...
Validation of less-invasive hemodynamic monitoring with Pulsioflex in critically ill patients
Critical Care, 2012
The respiratory abdominal variation test (RAVT): a noninvasive way to estimate abdominal wall compliance (Cab)
Fluids, 2012
Effect of enteral nutrition speed on intrafastric pressure measurement
American Surgeon, 2011
Impact of body anthropomorphic parameters on baseline intra-abdominal pressure measurements in critically ill patients
Fluids, 2012
Body antropomorphic data in relation to intra-abdominal pressure
American Surgeon, 2011
Fluids, 2012
Introduction. Nexfin (Bmeye, Amsterdam, Netherlands) is a noninvasive cardiac output (CO) monitor... more Introduction. Nexfin (Bmeye, Amsterdam, Netherlands) is a noninvasive cardiac output (CO) monitor based on finger arterial pulse contour analysis. The aim of this study was to validate Nexfin CO (NexCO) against thermodilution (TDCO) and pulse contour CO (CCO) by PiCCO (Pulsion Medical Systems, Munich, Germany). Patients and Methods. In a mix of critically ill patients (= 45), NexCO and CCO were measured continuously and recorded at 2-hour intervals during the 8-hour study period. TDCO was measured at 0-4-8 hrs. Results. NexCO showed a moderate to good (significant) correlation with TDCO (2 0.68, < 0.001) and CCO (2 0.71, < 0.001). Bland and Altman analysis comparing NexCO with TDCO revealed a bias (± limits of agreement, LA) of 0.4 ± 2.32 L/min (with 36% error) while analysis comparing NexCO with CCO showed a bias (±LA) of 0.2 ± 2.32 L/min (37% error). NexCO is able to follow changes in TDCO and CCO during the same time interval (level of concordance 89.3% and 81%). Finally, polar plot analysis showed that trending capabilities were acceptable when changes in NexCO (ΔNexCO) were compared to ΔTDCO and ΔCCO (resp., 89% and 88.9% of changes were within the level of 10% limits of agreement). Conclusion. we found a moderate to good correlation between CO measurements obtained with Nexfin and PiCCO.
Minerva anestesiologica, 2014
BACKGROUND Nexfin® (BMEYE, Amsterdam, The Netherlands) is a totally non-invasive blood pressure a... more BACKGROUND Nexfin® (BMEYE, Amsterdam, The Netherlands) is a totally non-invasive blood pressure and cardiac output (CO) monitor based on finger arterial pulse contour analysis. METHODS We performed an open observational study in a mix of medical-surgical-burns critically ill patients (N.=45) to validate Nexfin obtained blood pressures (MAPnex) against PiCCO (MAPfem) derived blood pressure measurements. MAPnex, MAPfem and corresponding systolic (SBP) and diastolic (DBP) blood pressures were measured continuously and registered with a 2 hour interval during the 8-hour study period. Statistical analysis was performed by Pearson regression, Bland and Altman, Concordance plot and Polar plot analysis. RESULTS MAPnex shows excellent correlation with MAPfem (R² 0.88, mean bias ± LA -2.3±12.4 mmHg, 14.7% error) and may be used interchangeably with invasive monitoring. The excellent MAPnex -MAPfem correlation was preserved in subgroup analysis for patients with severe hypotension, high system...
Validation study of Nexfin® continuous non-invasive blood pressure monitoring in critically ill adult patients
Minerva anestesiologica
Nexfin® (BMEYE, Amsterdam, The Netherlands) is a totally noninvasive blood pressure and cardiac o... more Nexfin® (BMEYE, Amsterdam, The Netherlands) is a totally noninvasive blood pressure and cardiac output (CO) monitor based on finger arterial pulse contour analysis. We performed an open observational study in a mix of medical-surgical-burns critically ill patients (n=45) to validate Nexfin obtained blood pressures (MAPnex) against PiCCO (MAPfem). derived blood pressure measurements. MAPnex, MAPfem and corresponding systolic (SBP) and diastolic (DBP) blood pressures were measured continuously and registered with a 2 hour interval during the 8-hour study period. Statistical analysis was performed by Pearson regression, Bland and Altman, Concordance plot and Polar plot analysis. MAPnex shows excellent correlation with MAPfem (R² 0.88, mean bias ± LA 2.3 ± 12.4 mmHg, 14.7% error) and may be used interchangeably with invasive monitoring. The excellent MAPnex MAPfem correlation was preserved in subgroup analysis for patients with severe hypotension, high systemic vascular resistance, low ...
Minerva anestesiologica, 2014
Nexfin® (BMEYE, Amsterdam, The Netherlands) is a totally non-invasive blood pressure and cardiac ... more Nexfin® (BMEYE, Amsterdam, The Netherlands) is a totally non-invasive blood pressure and cardiac output (CO) monitor based on finger arterial pulse contour analysis. We performed an open observational study in a mix of medical-surgical-burns critically ill patients (N.=45) to validate Nexfin obtained blood pressures (MAPnex) against PiCCO (MAPfem) derived blood pressure measurements. MAPnex, MAPfem and corresponding systolic (SBP) and diastolic (DBP) blood pressures were measured continuously and registered with a 2 hour interval during the 8-hour study period. Statistical analysis was performed by Pearson regression, Bland and Altman, Concordance plot and Polar plot analysis. MAPnex shows excellent correlation with MAPfem (R² 0.88, mean bias ± LA -2.3±12.4 mmHg, 14.7% error) and may be used interchangeably with invasive monitoring. The excellent MAPnex -MAPfem correlation was preserved in subgroup analysis for patients with severe hypotension, high systemic vascular resistance, low...
Validation of less-invasive hemodynamic monitoring with Pulsioflex in critically ill patients
Critical Care, 2012